Benkowitz Michael's Form 4 filing
United Therapeutics CorpUTHR · filed Mar 11, 2025
- Accession no.
- 0001562180-25-002291
- Filed
- Mar 11, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $640.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $111.00 | +$222,000 | 2,000 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −193 | $313.93 | −$60,588.49 | 1,807 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −200 | $317.11F3 | −$63,422 | 1,607 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −316 | $319.35F4 | −$100,914.6 | 1,291 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −533 | $320.57F5 | −$170,863.81 | 758 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −358 | $321.62F6 | −$115,139.96 | 400 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −300 | $322.86F7 | −$96,858 | 100 | Indirect | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −100 | $323.99 | −$32,399 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $316.76 to $317.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $319.09 to $320.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $320.09 to $320.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $321.10 to $321.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $322.285 to $323.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.